Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 2/3 × Myasthenia Gravis × rozanolixizumab × Clear all

Phase

Phase 3 6 Phase 4 1 Phase 2/3 1 Phase 2 1

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Conditions

Myasthenia Gravis 1

Interventions

zilucoplan 1 tocilizumab 1 rozanolixizumab 1 fludarabine 1 blinatumomab 1 Tablets 1 Cyclophosphamide 1 Albuterol 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT06149559 2026-02-27

roMyG

UCB Pharma

Phase 2/3 Recruiting

Myasthenia Gravis

Data powered by HemOnc (CC BY 4.0) Colophon ⚡